U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07667855) titled 'Peri-implant Soft Tissue Augmentation Using Microneedling With i-PRF vs. Connective Tissue ... Read More
U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07668141) titled 'Colistin Nephrotoxicity and Role of Alpha Lipoic Acid' on June 12. Brief Summary: Nephroto... Read More
U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07667387) titled 'A Phase I/II Open-label Safety and Efficacy Study of LNP.UCD.ABE in Patients With Urea Cycl... Read More
U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07668232) titled 'Efficacy and Safety of Mirabegron Versus Oxybutynin After Posterior Urethral Valve Ablation... Read More
U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07669441) titled 'Early Labor Pre-Marking for Epidural Analgesia: Ultrasound vs Manual Palpation' on June 21.... Read More
U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07667452) titled 'DevelopmentandApplication of a Single Feature Recognition Model for Heart Failure Based onA... Read More
U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07667478) titled 'NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE' on June 13. B... Read More
U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07668115) titled 'Gamifying Hand Therapy: Development of a Mixed Reality Rhythm Game to Reduce Pain and Impro... Read More
U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07669571) titled 'A Phase I Study of NS-079 in Healthy Participants' on June 16. Brief Summary: The goal of ... Read More
U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07667335) titled 'Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Local... Read More